Cargando…

Elevation in white blood cell count and development of hyper LDL cholesterolemia

To investigate the relationship between white blood cell (WBC) count and incidence of hyper-low-density lipoprotein (LDL) cholesterolemia in a population-based longitudinal study. This is a retrospective study using data of annual health check-ups for residents of Iki City, Japan. A total of 3312 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Okutsu, Shota, Kato, Yoshifumi, Takeoka, Hiroaki, Funakoshi, Shunsuke, Maeda, Toshiki, Yoshimura, Chikara, Kawazoe, Miki, Satoh, Atsushi, Tada, Kazuhiro, Takahashi, Koji, Ito, Kenji, Yasuno, Tetsuhiko, Fujii, Hideyuki, Mukoubara, Shigeaki, Saku, Keijiro, Kodama, Shohta, Kawanami, Daiji, Masutani, Kosuke, Arima, Hisatomi, Nabeshima, Shigeki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202917/
https://www.ncbi.nlm.nih.gov/pubmed/37217577
http://dx.doi.org/10.1038/s41598-023-35436-6
_version_ 1785045521118789632
author Okutsu, Shota
Kato, Yoshifumi
Takeoka, Hiroaki
Funakoshi, Shunsuke
Maeda, Toshiki
Yoshimura, Chikara
Kawazoe, Miki
Satoh, Atsushi
Tada, Kazuhiro
Takahashi, Koji
Ito, Kenji
Yasuno, Tetsuhiko
Fujii, Hideyuki
Mukoubara, Shigeaki
Saku, Keijiro
Kodama, Shohta
Kawanami, Daiji
Masutani, Kosuke
Arima, Hisatomi
Nabeshima, Shigeki
author_facet Okutsu, Shota
Kato, Yoshifumi
Takeoka, Hiroaki
Funakoshi, Shunsuke
Maeda, Toshiki
Yoshimura, Chikara
Kawazoe, Miki
Satoh, Atsushi
Tada, Kazuhiro
Takahashi, Koji
Ito, Kenji
Yasuno, Tetsuhiko
Fujii, Hideyuki
Mukoubara, Shigeaki
Saku, Keijiro
Kodama, Shohta
Kawanami, Daiji
Masutani, Kosuke
Arima, Hisatomi
Nabeshima, Shigeki
author_sort Okutsu, Shota
collection PubMed
description To investigate the relationship between white blood cell (WBC) count and incidence of hyper-low-density lipoprotein (LDL) cholesterolemia in a population-based longitudinal study. This is a retrospective study using data of annual health check-ups for residents of Iki City, Japan. A total of 3312 residents (≥ 30 years) without hyper-LDL cholesterolemia at baseline were included in this analysis. Primary outcome was incidence of hyper-LDL cholesterolemia (LDL cholesterol levels ≥ 3.62 mmol/L and/or use of lipid lowering drugs). During follow-up (average 4.6 years), 698 participants development of hyper-LDL cholesterolemia (incidence 46.8 per 1000 person-years). Higher incidence of hyper-LDL cholesterolemia was observed among participants with higher leukocyte count (1st quartile group: 38.5, 2nd quartile group: 47.7, 3rd quartile group: 47.3, and 4th quartile group: 52.4 per 1,000 person-years, P = 0.012 for trend). Statistically significant relation was observed even after adjustment for age, gender, smoking, alcohol intake, leisure-time exercise, obesity, hypertension and diabetes: hazard ratio 1.24 (95% confidence interval 0.99 to 1.54) for 2nd quartile group, 1.29 (1.03–1.62) for 3rd quartile group and 1.39 (1.10–1.75) for 4th quartile group, compared with 1st quartile group (P for trend = 0.006). Increased WBC count was related to incidence of hyper-LDL cholesterolemia in general Japanese population.
format Online
Article
Text
id pubmed-10202917
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102029172023-05-24 Elevation in white blood cell count and development of hyper LDL cholesterolemia Okutsu, Shota Kato, Yoshifumi Takeoka, Hiroaki Funakoshi, Shunsuke Maeda, Toshiki Yoshimura, Chikara Kawazoe, Miki Satoh, Atsushi Tada, Kazuhiro Takahashi, Koji Ito, Kenji Yasuno, Tetsuhiko Fujii, Hideyuki Mukoubara, Shigeaki Saku, Keijiro Kodama, Shohta Kawanami, Daiji Masutani, Kosuke Arima, Hisatomi Nabeshima, Shigeki Sci Rep Article To investigate the relationship between white blood cell (WBC) count and incidence of hyper-low-density lipoprotein (LDL) cholesterolemia in a population-based longitudinal study. This is a retrospective study using data of annual health check-ups for residents of Iki City, Japan. A total of 3312 residents (≥ 30 years) without hyper-LDL cholesterolemia at baseline were included in this analysis. Primary outcome was incidence of hyper-LDL cholesterolemia (LDL cholesterol levels ≥ 3.62 mmol/L and/or use of lipid lowering drugs). During follow-up (average 4.6 years), 698 participants development of hyper-LDL cholesterolemia (incidence 46.8 per 1000 person-years). Higher incidence of hyper-LDL cholesterolemia was observed among participants with higher leukocyte count (1st quartile group: 38.5, 2nd quartile group: 47.7, 3rd quartile group: 47.3, and 4th quartile group: 52.4 per 1,000 person-years, P = 0.012 for trend). Statistically significant relation was observed even after adjustment for age, gender, smoking, alcohol intake, leisure-time exercise, obesity, hypertension and diabetes: hazard ratio 1.24 (95% confidence interval 0.99 to 1.54) for 2nd quartile group, 1.29 (1.03–1.62) for 3rd quartile group and 1.39 (1.10–1.75) for 4th quartile group, compared with 1st quartile group (P for trend = 0.006). Increased WBC count was related to incidence of hyper-LDL cholesterolemia in general Japanese population. Nature Publishing Group UK 2023-05-22 /pmc/articles/PMC10202917/ /pubmed/37217577 http://dx.doi.org/10.1038/s41598-023-35436-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Okutsu, Shota
Kato, Yoshifumi
Takeoka, Hiroaki
Funakoshi, Shunsuke
Maeda, Toshiki
Yoshimura, Chikara
Kawazoe, Miki
Satoh, Atsushi
Tada, Kazuhiro
Takahashi, Koji
Ito, Kenji
Yasuno, Tetsuhiko
Fujii, Hideyuki
Mukoubara, Shigeaki
Saku, Keijiro
Kodama, Shohta
Kawanami, Daiji
Masutani, Kosuke
Arima, Hisatomi
Nabeshima, Shigeki
Elevation in white blood cell count and development of hyper LDL cholesterolemia
title Elevation in white blood cell count and development of hyper LDL cholesterolemia
title_full Elevation in white blood cell count and development of hyper LDL cholesterolemia
title_fullStr Elevation in white blood cell count and development of hyper LDL cholesterolemia
title_full_unstemmed Elevation in white blood cell count and development of hyper LDL cholesterolemia
title_short Elevation in white blood cell count and development of hyper LDL cholesterolemia
title_sort elevation in white blood cell count and development of hyper ldl cholesterolemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202917/
https://www.ncbi.nlm.nih.gov/pubmed/37217577
http://dx.doi.org/10.1038/s41598-023-35436-6
work_keys_str_mv AT okutsushota elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT katoyoshifumi elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT takeokahiroaki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT funakoshishunsuke elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT maedatoshiki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT yoshimurachikara elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT kawazoemiki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT satohatsushi elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT tadakazuhiro elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT takahashikoji elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT itokenji elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT yasunotetsuhiko elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT fujiihideyuki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT mukoubarashigeaki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT sakukeijiro elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT kodamashohta elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT kawanamidaiji elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT masutanikosuke elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT arimahisatomi elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia
AT nabeshimashigeki elevationinwhitebloodcellcountanddevelopmentofhyperldlcholesterolemia